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We are still far from reaching a complete understanding of the molecular mechanisms that control
neuronal diversification during nervous system development. In this issue of Neuron, Luo et al. bring
that goal a step closer by revealing how a hierarchical interaction between two neurotrophic factor
systems drives the differentiation, maturation, and extension of peripheral projections in a subclass
of sensory neurons that mediate pain perception.The molecular mechanisms responsi-
ble for the specification of distinct
sensory modalities are being intensely
investigated, not only because of the
obvious clinical importance of pain
control, but also as a powerful model
system of neuronal diversification.
Pain perception following harmful me-
chanical, thermal, and chemical stimuli
is mediated by the activation of pain-
transducing—i.e., nociceptive—sen-
sory neurons in the dorsal root ganglia
(DRG). Nociceptive, mechanoceptive,
and proprioceptive sensory neuron
subtypes emerge from migratory neu-
ral crest cells shortly after neural tube
closure and continue to diversify by
acquiring distinct functional character-
istics long after birth (Hjerling-Leffler
et al., 2007). Nociceptors express a
diverse collection of ion channels thatallow them to transduce external stim-
uli into electrical activity. The genera-
tion of nociceptor cell diversity is be-
lieved to be controlled by hierarchical
interactions between cell intrinsic and
extrinsic signals (Marmigere and Ern-
fors, 2007). All nociceptive neurons ini-
tially express the transcription factor
Runx1 and the nerve growth factor
(NGF) receptor TrkA, which mediates
target-dependent cell survival during
the period of programmed cell death.
Around birth, and during the first 2 to
3 postnatal weeks, a fraction of noci-
ceptive neurons switch their neuro-
trophic factor dependence by down-
regulating expression of TrkA and
upregulating that of Ret, a signaling
subunit of the receptor complex for
members of the GDNF (glial cell line-
derived neurotrophic factor) ligandNeuron 5family. TrkA+ and Ret+ nociceptors
are also distinguished by the presence
or absence of the neuropeptides calci-
tonin gene-related peptide (CGRP)
and substance P (SP)—hence classi-
fied as peptidergic or nonpeptidergic
subtypes—and believed to mediate
inflammatory or neuropathic pain,
respectively. While developing non-
peptidergic nociceptors lose TrkA,
maintain Runx1, and gain Ret expres-
sion, peptidergic sensory neurons
retain TrkA but lose Runx1 as they
mature (Chen et al., 2006).
The contribution of NGF/TrkA sig-
naling to sensory neuron diversifica-
tion and maturation has been studied
in mice lacking the proapoptotic mole-
cule Bax, a mutation that bypasses the
early developmental requirement of
neurotrophic support for cell survival.4, June 7, 2007 ª2007 Elsevier Inc. 673
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Bax-deficient DRG neurons failed to
express multiple phenotypic markers
that are characteristic of both pepti-
dergic and nonpeptidergic nociceptive
neurons, including CGRP/SP and Ret,
respectively (Patel et al., 2000), under-
lying the importance of NGF and TrkA
for the development of the nociceptive
sensory phenotype in vivo. A more re-
cent study examined the role of Runx1
in nociceptive development using con-
ditional knockout mice in which spe-
cific Runx1 deletion in premigratory
neural crest cells, including the pro-
genitors of DRG neurons, was con-
trolled by a Wnt1-Cre transgene
(Chen et al., 2006). Runx1 was found
to be required for most if not all
aspects of the nonpeptidergic noci-
ceptive phenotype, including upregu-
lation of Ret, downregulation of TrkA,
expression of a distinct set of ion
channels and sensory receptors, and
central target selection in the dorsal
spinal cord. As a consequence,
Runx1 mutants displayed deficits in
thermal and neuropathic pain re-
sponses, indicating the important role
of Runx1 as a master regulator of the
nonpeptidergic phenotype in develop-
ing nociceptive sensory neurons (Chen
et al., 2006). Interestingly, an expan-
sion of the peptidergic fate, character-
ized by increased numbers of CGRP-
and TrkA-expressing neurons, was
also observed in the absence of
Runx1, leading to the idea that Runx1
may function as a direct repressor of
the peptidergic fate associated with
a TrkA identity (Chen et al., 2006).
Although transcription factors acting
as activators and repressors in the
same cell lineage are not an exception,
a possibility not addressed by previ-
ous studies was that other effectors,
downstream of Runx1, may be in-
volved in TrkA extinction and neuro-
peptide gene repression.
Enter the paper by Luo et al. (2007) in
this issue ofNeuron. These authors set
out to investigate the role of Ret signal-
ing in sensory neuron development for
which they developed a conditional
knockout of the Ret gene in DRG pre-
cursors driven by the Wnt1-Cre trans-
gene. In these mice, Ret expression
was lost in DRG neurons as well as674 Neuron 54, June 7, 2007 ª2007 Elsemyenteric plexus and sympathetic
ganglia. Although grossly normal at
birth, these mutants developed ab-
dominal distension and progressive
weakness, resulting in most mice dying
within 3 weeks of age due to enteric
aganglionosis. Luo et al. (2007) found
that Ret was not required for DRG cell
viability but was necessary for normal
soma size and extension of cutaneous
peripheral projections by nonpeptider-
gic sensory neurons. In agreement with
this, the GDNF family member Neu-
rturin has been found to be expressed
at high levels in skin (Golden et al.,
1999), and loss of either Neurturin or
its cognate coreceptor GFRa2—with
which Ret forms a functional signaling
complex—results in reduced sensory
neuron soma size and peripheral inner-
vation defects similar to those ob-
served by Luo et al. (Heuckeroth
et al., 1999; Lindfors et al., 2006). A
survey of GFRa family members ex-
pressed in DRG neurons made by Luo
et al. (2007) identified GFRa2 as the
most abundant coreceptor in those
cells. Moreover, the authors found
that GFRa2 expression was (at least
partially) under Ret control, suggesting
that Neurturin positively regulates the
expression of its own receptor in neu-
rons expressing Ret. Intriguingly, no
defect in central projections was ob-
served in conditionalRetmutants, indi-
cating that other target-derived signals
may control spinal cord innervation
and termination by nonpeptidergic
sensory neurons.
Importantly, Luo et al. (2007) found
that Ret is required for the acquisition
of several aspects of the nonpeptider-
gic phenotype of DRG neurons. Sev-
eral markers that are characteristic of
these neurons were absent in DRG
lacking Ret, including the Trp class
ion channel TrpA1, and G protein cou-
pled receptors MrgA1, MrgA3, and
MrgB4. Other aspects of the nonpep-
tidergic phenotype, however, were
not affected by the absence of Ret,
such as expression of TrpC3, TrpV1,
MrgD, and the ATP-gated channel
P2X3, indicating that Ret signaling
controls a subset of the genes that
characterize mature nonpeptidergic
sensory neurons. Although expression
of the cold and menthol receptorvier Inc.TrpM8 was neither affected by the
loss of Ret, a recent study has found
no overlap between TrpM8 and the
nonpeptidergic marker IB4 (Hjerling-
Leffler et al., 2007), indicating that
this channel may actually be restricted
to nociceptive neurons of the peptider-
gic subclass. Nevertheless, both
Ret-dependent and Ret-independent
markers, as well as Ret itself, are in
turn controlled by Runx1, suggesting
that the activity of this transcription
factor unleashes divergent signaling
cascades that control different as-
pects of the nonpeptidergic nocicep-
tive phenotype. As Runx1 is also re-
quired for TrpM8 expression (Chen
et al., 2006), aspects of the peptidergic
phenotype may also be controlled by
this transcription factor. Whether Ret-
independent genes, such as TrpC3,
TrpV1, MrgD, and P2X3, are regulated
by Runx1 directly or via other sets
of extracellular signals remains to be
elucidated.
Is TrkA extinction in nonpeptidergic
nociceptive neurons Ret-dependent
or Ret-independent? Luo et al. finds
the answer to be both. By P14, most
nonpeptidergic DRG neurons have
normally downregulated TrkA expres-
sion almost completely, while roughly
half of the neurons lacking Ret failed
to do so, indicating that Ret signaling
is an important step, albeit not the
only one, in the postnatal extinction
of TrkA expression in nonpeptidergic
sensory neurons. More generally, this
result suggests that pathways acti-
vated downstream of Runx1, rather
than Runx1 itself, may act to suppress
the expression of genes normally as-
sociated with the peptidergic pheno-
type in sensory neurons.
A final question addressed by Luo
et al. (2007) concerns the identity of
the signals lying upstream of Runx1
and how these relate to the control of
gene expression in nonpeptidergic no-
ciceptors. Because of its early onset
during sensory neuron development,
NGF/TrkA signaling stood out as
a strong candidate for this role. Using
double-mutant mice lacking both
NGF and Bax the authors could
show a drastic—albeit not complete—
reduction in Runx1 expression in new-
born DRG. This was accompanied
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tion of several characteristic
nonpeptidergic markers, in-
cluding TrpC3, MrgA1, MrgA3,
MrgD. However, other
markers—such as TrpV1 and
P2X3—were only slightly re-
duced or unaffected by the
loss of NGF/TrkA signaling. As
both TrpV1 and P2X3 are only
partially reduced in DRG lack-
ing Runx1 (Chen et al., 2006),
together these data suggest
that NGF/TrkA- and Runx1-in-
dependent pathways will also
contribute to some aspects of
the nonpeptidergic phenotype
in DRG nociceptors. Interest-
ingly, Luo et al. (2007) found
that expression of Runx1 was
unaffected in NGF/Bax double
mutants at embryonic day 14
(E14), suggesting that NGF/
TrkA signaling is not required
for the initiation of Runx1 expression
but for its maintenance during later
stages. Thus, it would appear that
Runx1 expression becomes under
the control of NGF/TrkA signaling just
around the period in which nonpepti-
dergic nociceptors switch from TrkA
to Ret.
The picture that emerges from this
and other recent studies on the control
of nociceptive neuron diversity is that
of a regulatory network of mutually re-
inforcing feed-forward and negative
feedback loops (Figure 1). Switch-like
behaviors are not uncommon among
signaling networks with this type of
configuration. The ability of TrkA sig-
naling to maintain postnatal Runx1
expression in only a subset of nocicep-
tive neurons could explain why pepti-
dergic nociceptors fail to express Ret
despite also expressing TrkA; e.g.,
these cells may lack molecular com-
ponents required for this activity. Alter-
natively, or in addition, different levels
of TrkA signaling may be reached in
the two sensory neuron subclasses,
with only the highest level being suffi-
cient for maintaining Runx1. Finally,
suppression of Runx1 expression by
a component specifically induced in
peptidergic neurons could also con-
tribute to reinforcing the segregation
of this transcription factor among dif-
ferent nociceptor subclasses in post-
natal stages (X in Figure 1). As Runx1
would also appear to be required for
some aspects of the peptidergic phe-
notype (e.g., TrpM8 expression), per-
haps acting during earlier develop-
mental stages, an important task for
future studies will be to carefully estab-
lish the timing of Runx1 extinction in
relation to different maturation events
in peptidergic nociceptors. Given the
requirement of TrkA signaling for post-
natal Runx1 expression in nonpepti-
dergic neurons, another question
raised by these data is how Runx1 is
maintained in these cells after TrkA
expression is extinguished. Luo et al.
(2007) show that Ret signaling is not
required for this function, at least not
by P14 (although it could possibly be
so later on), suggesting that another
positive feedback loop may reinforce
Runx1 expression after nonpeptider-
gic nociceptors turn off TrkA, either
through autoregulation or via other
downstream components (Y in Fig-
ure 1). The existence of additional
components downstream of Runx1
and alongside Ret could be expected
by the fact that several differentiation
events in nonpeptidergic neu-
rons appear to be Ret-indepen-
dent. As indicated by Luo et al.
(2007), intrinsic transcriptional
programs may be responsible
for the onset of Runx1 expres-
sion during embryonic sensory
neuron development, and
some of these could also play
a role during postnatal stages
(Z in Figure 1).
In summary, the study by Luo
et al. (2007) substantially ex-
pands our understanding of
the mechanisms by which dif-
ferent types of nociceptive neu-
rons emerge during develop-
ment. Hierarchical interactions
between different neurotrophic
factor systems may explain
how a limited set of neurotro-
phic signals orchestrates differ-
ent stages of neuronal develop-
ment. More generally, this study
demonstrates how cell-extrinsic sig-
nals, such as those mediated by neuro-
trophic factors, modulate the function
of cell-intrinsic transcription factors to
dictate different phenotypic outcomes.
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Figure 1. An Emerging Regulatory Network of
Nociceptive Sensory Neuron Development
The regulatory connections shown correspond for the most
part to those found during postnatal stages and are likely to
differ at earlier stages of development (during which Runx1
may also play roles in peptidergic differentiation). Dashed lines
and X, Y, and Z denote hypothetical regulatory connections
and components, respectively. See text for details.Neuron 54, June 7, 2007 ª2007 Elsevier Inc. 675
